EPH25 Adverse Drug Events Associated with Immune Checkpoint Inhibitors Atezolizumab, Nivolumab and Pembrolizumab: A Descriptive Retrospective Pharmacoepidemiologic Analysis Using FAERS Database 2014-2021
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.907
https://www.valueinhealthjournal.com/article/S1098-3015(23)01007-0/fulltext
Title :
EPH25 Adverse Drug Events Associated with Immune Checkpoint Inhibitors Atezolizumab, Nivolumab and Pembrolizumab: A Descriptive Retrospective Pharmacoepidemiologic Analysis Using FAERS Database 2014-2021
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)01007-0&doi=10.1016/j.jval.2023.03.907
First page :
Section Title :
Open access? :
No
Section Order :
10358